DUSP6 and pancreatic neoplasm: While the expression of DUSP6 is markedly reduced in pancreatic cancer cells, the expression of DUSP6 can be restored by treatment with 5-azacytidine, an inhibitor of DNA methyltransferase, which indicates that the reduced expression stems from hypermethylation.